Clinical Study Results
Research Sponsor: Acerta Pharma BV
Drugs Studied: • AZD9150 • Hu5F9-G4
• AZD6738 • rituximab
• AZD5153 • acalabrutinib
Study Purpose: This study was done to learn about the safety
of 4 different combination treatments in
adults with relapsed or refractory
non-Hodgkin’s lymphoma.
Protocol Number: D9820C00001
Thank you
Thank you for taking part in the clinical study for the study drugs AZD9150,
AZD6738, AZD5153, Hu5F9-G4, rituximab, and acalabrutinib. This study
investigated 4 different combinations of these treatments in people with non-
Hodgkin’s lymphoma.
Acerta Pharma BV sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you.
If you participated in the study and have questions about the results, please
speak with the study doctor or staff at your study site.
1